Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Baclofen 10mg tablets
1002020C0AAAIAI
|
Baclofen | Baclofen | Musculoskeletal and Joint Diseases | 128,082 |
|
Baclofen 5mg/5ml oral solution sugar free
1002020C0AAABAB
|
Baclofen | Baclofen | Musculoskeletal and Joint Diseases | 32,999 |
|
Baclofen 10mg/5ml oral solution sugar free
1002020C0AABGBG
|
Baclofen | Baclofen | Musculoskeletal and Joint Diseases | 1,472 |
|
Baclofen 5mg tablets
1002020C0AABIBI
|
Baclofen | Baclofen | Musculoskeletal and Joint Diseases | 1,257 |
|
Baclofen 20mg tablets
1002020C0AABHBH
|
Baclofen | Baclofen | Musculoskeletal and Joint Diseases | 124 |
|
Baclofen 20mg/5ml oral liquid
1002020C0AABDBD
|
Baclofen | Baclofen | Musculoskeletal and Joint Diseases | 9 |
|
Baclofen 5mg/5ml oral suspension
1002020C0AAA1A1
|
Baclofen | Baclofen | Musculoskeletal and Joint Diseases | 3 |
|
Baclofen 15mg/5ml oral liquid
1002020C0AABEBE
|
Baclofen | Baclofen | Musculoskeletal and Joint Diseases | 1 |
|
Baclofen 10mg/20ml solution for infusion ampoules
1002020C0AAA4A4
|
Baclofen | Baclofen | Musculoskeletal and Joint Diseases | No data available |
|
Baclofen 10mg/5ml solution for infusion ampoules
1002020C0AAA3A3
|
Baclofen | Baclofen | Musculoskeletal and Joint Diseases | No data available |
|
Baclofen 2mg/5ml oral liquid
1002020C0AAA8A8
|
Baclofen | Baclofen | Musculoskeletal and Joint Diseases | No data available |
|
Baclofen 40mg/20ml solution for infusion ampoules
1002020C0AABFBF
|
Baclofen | Baclofen | Musculoskeletal and Joint Diseases | No data available |
|
Baclofen 50micrograms/1ml solution for injection ampoules
1002020C0AAA2A2
|
Baclofen | Baclofen | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.